Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes

  • Takao Arai
  • , Ofra Benny
  • , Tatsuhiro Joki
  • , Lata G. Menon
  • , Marcelle Machluf
  • , Toshiaki Abe
  • , Rona S. Carroll
  • , Peter M. Black

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

Background: The purpose of our study was to evaluate the application of thermoreversible gelation polymer (TGP) as a local drug delivery system for malignant glioma. Materials and Methods: Polymeric microspheres or liposomes loaded with doxorubicin (sphere-dox or lipo-dox) were combined with TGP to provide continuous drug delivery of doxorubicin (dox) for kinetic release studies and cell viability assays on glioma cell lines in vitro. For in vivo studies, TGP loaded with dox alone (TGP-dox) was combined with sphere-dox or lipo-dox. Their antitumor effects on subcutaneous human glioma xenografts were evaluated in nude mice. Results: In vitro, TGP combined with sphere-dox or lipo-dox released dox for up to 30 days. In vivo, TGP-dox combined with sphere-dox or lipo-dox inhibited subcutaneous glioma tumor growth until day 32 and day 38, respectively. Conclusion: TGP in combination with microspheres or liposomes successfully prolonged the release of dox and its antitumor effects.

Original languageEnglish
Pages (from-to)1057-1064
Number of pages8
JournalAnticancer Research
Volume30
Issue number4
StatePublished - Apr 2010
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Doxorubicin
  • Drug delivery system
  • Liposome
  • Malignant glioma
  • Polymeric microsphere
  • Thermoreversible gelation polymer

Fingerprint

Dive into the research topics of 'Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes'. Together they form a unique fingerprint.

Cite this